ArticleChemical & biomedical imaging2026
Super-Resolution Microscopy Reveals Nanoscale Arrangement of PD-L1 Immune Checkpoint.
Article in Chemical & biomedical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Imaging from Macro to Nanoscale: Multimodal Advances in Chemical and Biomedical Imaging.Chemical & biomedical imaging · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PD-L1 is an immune checkpoint protein widely expressed in cancer cells, maintaining the tolerance of antitumor immunity by engaging with its receptor PD-1 on T cells. However, the spatial organization of PD-L1 on the cell membrane is poorly understood. Here, we employ stochastic optical reconstruction microscopy (STORM) integrated with analytical methods to quantitatively reveal the nanoscale arrangement of PD-L1 in breast cancer cells. Results show that PD-L1 is distributed randomly on the cell membrane as monomers. Further, treatments with drugs such as IFN-γ, 2-DG, and simvastatin modulate the density of PD-L1 without affecting its monomeric state. By STORM, combining 2nd antibody-induced cross-linking and fluorescence recovery after photobleaching, we demonstrate that PD-L1 exhibits high lateral mobility and clustering capability. Additional results reveal that paraformaldehyde, a common fixative, is inadequate for fixing PD-L1 for super-resolution imaging. Finally, we observed that PD-L1 forms nanoclusters at cell-cell conjugation sites between breast cancer cells and T cells. Overall, these findings based on STORM extend our understanding of the nanoscale organization of PD-L1 on the membrane.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.